Keep up to date with our latest partnering deals and highlights

Below is a selection of news releases describing recent deals completed by AstraZeneca and our biologics arm, MedImmune.

Thursday, 10 July 2014
New drug active against most aggressive type of lung cancer cells Manchester scientists have shown that a new drug could prove useful in treating small cell lung cancer - the most aggressive form of lung cancer.
Thursday, 3 July 2014
MRC Technology and AstraZeneca Renew Collaboration to Identify Novel Targets for Discovery Research Initiative brings together global expertise to share compound libraries and streamline drug discovery
Thursday, 12 June 2014
AstraZeneca in-licenses Synairgen’s SNG001 as a novel immuno-modulatory therapy for viral-induced exacerbation in asthma Phase IIa clinical study to commence in patients with severe asthma
Download our brochure

Download your comprehensive guide to partnering with us.

Meet us at an event

Calendar iconView our full event calendar to see events we are attending.

View calendar